Regulation of the Melanocortin-Sensitive Adenylate Cyclase System by N-Acylated Peptide 71-82 of Type 4 Melanocortin Receptor
- 55 Downloads
The peptides structurally corresponding in to cytoplasmic loops of G protein-coupled receptors (GPCR) are able to control functional activity of homologous receptors and the corresponding signaling pathways. Modification of these peptides with hydrophobic radicals enhances their biological activity due to penetration of lipophilic derivatives through the membrane and anchoring near their targets, GPCR. We synthesized an N-palmitoylated peptide Palm-Val-[Lys-Asn-Lys-Asn-Leu-His-Ser-Pro-(Nle)-Tyr-Phe-Phe71-82]-amide-Palm-Val-(71-82) structurally corresponding to cytoplasmic loop 1 of melanocortin 4 receptor (M4R). We found that in micromolar concentrations it very effectively suppresses stimulation of basal adenylate cyclase activity and basal level of GppNHp binding of heterotrimeric G proteins produced by THIQ and α-melanocyte stimulating hormone (α-MSH), agonists of M4R homologous to the peptide, in synaptosomal membranes of rat brain. The peptide Palm-Val-(71-82) also reduced, albeit to a significantly less extent, stimulation of adenylate cyclase and G-proteins by M3R agonist of γ-MSH, due to high homology of the peptide primary structure to M3R cytoplasmic loop 1. The synthesized peptide with activity of M4R/M3R antagonist can be used for the development of regulators of M4R and M3R and the corresponding biochemical and physiological processes.
Key Words
adenylate cyclase melanocortin receptor brain peptide cytoplasmic loop 1Preview
Unable to display preview. Download preview PDF.
References
- 1.E. A. Shpakova, K. V. Derkach, and A. O. Shpakov, Bull. Exp. Biol. Med., 156, No. 5, 658-662 (2014).CrossRefPubMedGoogle Scholar
- 2.E. A. Shpakova, K. V. Derkach, and A. O. Shpakov, Dokl. Akad Nauk, 452, No. 4, 453 (2013).Google Scholar
- 3.A. O. Shpakov E. A. Shpakova, I. I. Tarasenko, and K. V. Derkach, Biol. Membrany, 28, No. 6, 453-462 (2011).Google Scholar
- 4.J. Cisowski, K. O’Callaghan, A. Kuliopulos, et al., Am. J. Pathol., 179, No. 1, 513-523 (2011).PubMedCentralCrossRefPubMedGoogle Scholar
- 5.L. Covic, M. Misra, J. Badar, et al., Nat. Med., 8, No. 10, 1161-1165 (2002).CrossRefPubMedGoogle Scholar
- 6.A. J. Leger, S. L. Jacques, J. Badar, et al., Circulation, 113, No. 9, 1244-1254 (2006).CrossRefPubMedGoogle Scholar
- 7.R. Nogueiras, P. Wiedmer, D. Perez-Tilve, et al., J. Clin. Invest., 117, No. 11, 3475-3488 (2007).PubMedCentralCrossRefPubMedGoogle Scholar
- 8.K. O’Callaghan, L. Lee, N. Nguyen, et al., Blood, 119, No. 7, 1717-1725 (2012).PubMedCentralCrossRefPubMedGoogle Scholar
- 9.T. Okubo and S. Chaki, Cur. Top. Med. Chem., 7, No. 11, 1145-1151 (2013).CrossRefGoogle Scholar
- 10.H. Shinyama, H. Masuzaki, H. Fang, and J. S. Flier, Endocrinology, 144, No. 4, 1301-1314 (2003).CrossRefPubMedGoogle Scholar
- 11.A. O. Shpakov, J. Amino Acids, 2011, doi: 10.4061/2011/656051 (2011).
- 12.A. O. Shpakov and M. N. Pertseva, Signal Transduction Research Trends, Ed. N. O. Grachevsky. New York (2007), pp. 45-93.Google Scholar
- 13.A. O. Shpakov, E. A. Shpakova, I. I. Tarasenko, et al., Int. J. Pept. Res. Ther., 16, No. 2, 95-105 (2010).CrossRefGoogle Scholar
- 14.S. L. Tressel, G. Koukos, B. Tchernychev, et al., Methods Mol. Biol., 683, 259-275 (2011).PubMedCentralCrossRefPubMedGoogle Scholar
- 15.Y. Xu, J. K. Elmquist, and M. Fukuda, Ann. N.Y. Acad. Sci., 1243, 1-14 (2011).PubMedCentralCrossRefPubMedGoogle Scholar